APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Medical Cannabidiol

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Medical Cannabidiol Market Outlook and Growth Opportunities 2026

4 July 2026190 pages

Choose your research edition.

Industry ResearchPet Medical Cannabidiol Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Medical Cannabidiol Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Pet Medical Cannabidiol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Medical Cannabidiol Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Medical Cannabidiol Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pet Medical Cannabidiol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Medical Cannabidiol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Medical Cannabidiol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Medical Cannabidiol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Medical Cannabidiol market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Medical Cannabidiol market include Canna-Pet, Holistic Hound, BATCH, Choom Holdings, Receptra Naturals, Curaleaf, Trulieve Cannabis, Pure Spectrum and Cannabis Strategies Acquisition, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Medical Cannabidiol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Medical Cannabidiol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Medical Cannabidiol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Medical Cannabidiol market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Medical Cannabidiol Segment by Company

Canna-Pet

Holistic Hound

BATCH

Choom Holdings

Receptra Naturals

Curaleaf

Trulieve Cannabis

Pure Spectrum

Cannabis Strategies Acquisition

Pet Releaf

Diamond CBD

PotNetwork Holdings

Kat's Naturals

Bluebird Botanicals

Pet Medical Cannabidiol Segment by Type

Oral Cannabidiol

Topical Cannabidiol

Pet Medical Cannabidiol Segment by Application

Anaesthetization

Stimulate Appetite

Relieve Anxiety

Others

Pet Medical Cannabidiol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Medical Cannabidiol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Medical Cannabidiol market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Medical Cannabidiol significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Medical Cannabidiol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Medical Cannabidiol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Medical Cannabidiol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Medical Cannabidiol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Medical Cannabidiol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Medical Cannabidiol industry.

Chapter 3: Detailed analysis of Pet Medical Cannabidiol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Medical Cannabidiol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Medical Cannabidiol in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Medical Cannabidiol Industry Trends Table 2. Pet Medical Cannabidiol Industry Drivers Table 3. Pet Medical Cannabidiol Industry Opportunities and Challenges Table 4. Pet Medical Cannabidiol Industry Restraints Table 5. Global Pet Medical Cannabidiol Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Medical Cannabidiol Revenue Share by Company (2021-2026) Table 7. Global Pet Medical Cannabidiol Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pet Medical Cannabidiol Sales Volume Share by Company (2021-2026) Table 9. Global Pet Medical Cannabidiol Average Price (USD/unit) of Company (2021-2026) Table 10. Global Pet Medical Cannabidiol Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Medical Cannabidiol Key Company Manufacturing Base & Headquarters Table 12. Global Pet Medical Cannabidiol Company, Product Type & Application Table 13. Global Pet Medical Cannabidiol Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Medical Cannabidiol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Cannabidiol Table 18. Significant Companies of Topical Cannabidiol Table 19. Global Pet Medical Cannabidiol Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Pet Medical Cannabidiol Sales Volume by Type (2021-2026) & (k units) Table 21. Global Pet Medical Cannabidiol Sales Volume by Type (2027-2032) & (k units) Table 22. Global Pet Medical Cannabidiol Sales Volume Share by Type (2021-2026) Table 23. Global Pet Medical Cannabidiol Sales Volume Share by Type (2027-2032) Table 24. Global Pet Medical Cannabidiol Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pet Medical Cannabidiol Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pet Medical Cannabidiol Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pet Medical Cannabidiol Sales Value Share by Type (2021-2026) Table 28. Global Pet Medical Cannabidiol Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Anaesthetization Table 30. Significant Companies of Stimulate Appetite Table 31. Significant Companies of Relieve Anxiety Table 32. Significant Companies of Others Table 33. Global Pet Medical Cannabidiol Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Pet Medical Cannabidiol Sales Volume by Application (2021-2026) & (k units) Table 35. Global Pet Medical Cannabidiol Sales Volume by Application (2027-2032) & (k units) Table 36. Global Pet Medical Cannabidiol Sales Volume Share by Application (2021-2026) Table 37. Global Pet Medical Cannabidiol Sales Volume Share by Application (2027-2032) Table 38. Global Pet Medical Cannabidiol Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pet Medical Cannabidiol Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pet Medical Cannabidiol Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pet Medical Cannabidiol Sales Value Share by Application (2021-2026) Table 42. Global Pet Medical Cannabidiol Sales Value Share by Application (2027-2032) Table 43. Global Pet Medical Cannabidiol Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Pet Medical Cannabidiol Sales by Region (2021-2026) & (k units) Table 45. Global Pet Medical Cannabidiol Sales Market Share by Region (2021-2026) Table 46. Global Pet Medical Cannabidiol Sales by Region (2027-2032) & (k units) Table 47. Global Pet Medical Cannabidiol Sales Market Share by Region (2027-2032) Table 48. Global Pet Medical Cannabidiol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pet Medical Cannabidiol Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pet Medical Cannabidiol Sales Value Share by Region (2021-2026) Table 51. Global Pet Medical Cannabidiol Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pet Medical Cannabidiol Sales Value Share by Region (2027-2032) Table 53. Global Pet Medical Cannabidiol Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Pet Medical Cannabidiol Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Pet Medical Cannabidiol Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Pet Medical Cannabidiol Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 58. Global Pet Medical Cannabidiol Sales Market Share by Country (2021-2026) Table 59. Global Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 60. Global Pet Medical Cannabidiol Sales Market Share by Country (2027-2032) Table 61. Global Pet Medical Cannabidiol Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pet Medical Cannabidiol Sales Value Market Share by Country (2021-2026) Table 63. Global Pet Medical Cannabidiol Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pet Medical Cannabidiol Sales Value Market Share by Country (2027-2032) Table 65. Canna-Pet Company Information Table 66. Canna-Pet Business Overview Table 67. Canna-Pet Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Canna-Pet Pet Medical Cannabidiol Product Portfolio Table 69. Canna-Pet Recent Development Table 70. Holistic Hound Company Information Table 71. Holistic Hound Business Overview Table 72. Holistic Hound Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Holistic Hound Pet Medical Cannabidiol Product Portfolio Table 74. Holistic Hound Recent Development Table 75. BATCH Company Information Table 76. BATCH Business Overview Table 77. BATCH Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. BATCH Pet Medical Cannabidiol Product Portfolio Table 79. BATCH Recent Development Table 80. Choom Holdings Company Information Table 81. Choom Holdings Business Overview Table 82. Choom Holdings Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Choom Holdings Pet Medical Cannabidiol Product Portfolio Table 84. Choom Holdings Recent Development Table 85. Receptra Naturals Company Information Table 86. Receptra Naturals Business Overview Table 87. Receptra Naturals Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Receptra Naturals Pet Medical Cannabidiol Product Portfolio Table 89. Receptra Naturals Recent Development Table 90. Curaleaf Company Information Table 91. Curaleaf Business Overview Table 92. Curaleaf Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Curaleaf Pet Medical Cannabidiol Product Portfolio Table 94. Curaleaf Recent Development Table 95. Trulieve Cannabis Company Information Table 96. Trulieve Cannabis Business Overview Table 97. Trulieve Cannabis Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Trulieve Cannabis Pet Medical Cannabidiol Product Portfolio Table 99. Trulieve Cannabis Recent Development Table 100. Pure Spectrum Company Information Table 101. Pure Spectrum Business Overview Table 102. Pure Spectrum Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Pure Spectrum Pet Medical Cannabidiol Product Portfolio Table 104. Pure Spectrum Recent Development Table 105. Cannabis Strategies Acquisition Company Information Table 106. Cannabis Strategies Acquisition Business Overview Table 107. Cannabis Strategies Acquisition Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Cannabis Strategies Acquisition Pet Medical Cannabidiol Product Portfolio Table 109. Cannabis Strategies Acquisition Recent Development Table 110. Pet Releaf Company Information Table 111. Pet Releaf Business Overview Table 112. Pet Releaf Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Pet Releaf Pet Medical Cannabidiol Product Portfolio Table 114. Pet Releaf Recent Development Table 115. Diamond CBD Company Information Table 116. Diamond CBD Business Overview Table 117. Diamond CBD Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Diamond CBD Pet Medical Cannabidiol Product Portfolio Table 119. Diamond CBD Recent Development Table 120. PotNetwork Holdings Company Information Table 121. PotNetwork Holdings Business Overview Table 122. PotNetwork Holdings Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. PotNetwork Holdings Pet Medical Cannabidiol Product Portfolio Table 124. PotNetwork Holdings Recent Development Table 125. Kat's Naturals Company Information Table 126. Kat's Naturals Business Overview Table 127. Kat's Naturals Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Kat's Naturals Pet Medical Cannabidiol Product Portfolio Table 129. Kat's Naturals Recent Development Table 130. Bluebird Botanicals Company Information Table 131. Bluebird Botanicals Business Overview Table 132. Bluebird Botanicals Pet Medical Cannabidiol Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Bluebird Botanicals Pet Medical Cannabidiol Product Portfolio Table 134. Bluebird Botanicals Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Pet Medical Cannabidiol Distributors List Table 138. Pet Medical Cannabidiol Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Pet Medical Cannabidiol Product Image Figure 2. Global Pet Medical Cannabidiol Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Medical Cannabidiol Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Medical Cannabidiol Sales (2021-2032) & (k units) Figure 5. Global Pet Medical Cannabidiol Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Pet Medical Cannabidiol Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Cannabidiol Image Figure 10. Topical Cannabidiol Image Figure 11. Global Pet Medical Cannabidiol Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Pet Medical Cannabidiol Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pet Medical Cannabidiol Sales Volume Share by Type (2021-2032) Figure 14. Global Pet Medical Cannabidiol Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pet Medical Cannabidiol Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pet Medical Cannabidiol Sales Value Share by Type (2021-2032) Figure 17. Anaesthetization Image Figure 18. Stimulate Appetite Image Figure 19. Relieve Anxiety Image Figure 20. Others Image Figure 21. Global Pet Medical Cannabidiol Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Pet Medical Cannabidiol Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pet Medical Cannabidiol Sales Volume Share by Application (2021-2032) Figure 24. Global Pet Medical Cannabidiol Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pet Medical Cannabidiol Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pet Medical Cannabidiol Sales Value Share by Application (2021-2032) Figure 27. Global Pet Medical Cannabidiol Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Pet Medical Cannabidiol Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pet Medical Cannabidiol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pet Medical Cannabidiol Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pet Medical Cannabidiol Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pet Medical Cannabidiol Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pet Medical Cannabidiol Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pet Medical Cannabidiol Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pet Medical Cannabidiol Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pet Medical Cannabidiol Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pet Medical Cannabidiol Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pet Medical Cannabidiol Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pet Medical Cannabidiol Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pet Medical Cannabidiol Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pet Medical Cannabidiol Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pet Medical Cannabidiol Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Cannabidiol
  • Topical Cannabidiol
Applications
  • Anaesthetization
  • Stimulate Appetite
  • Relieve Anxiety
  • Others
Companies covered
  • Canna-Pet
  • Holistic Hound
  • BATCH
  • Choom Holdings
  • Receptra Naturals
  • Curaleaf
  • Trulieve Cannabis
  • Pure Spectrum
  • Cannabis Strategies Acquisition
  • Pet Releaf
  • Diamond CBD
  • PotNetwork Holdings
  • Kat's Naturals
  • Bluebird Botanicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Medical Cannabidiol Sales Value (2021-2032)
  4. 1.2.2 Global Pet Medical Cannabidiol Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Medical Cannabidiol Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Medical Cannabidiol Market Dynamics
  1. 2.1 Pet Medical Cannabidiol Industry Trends
  2. 2.2 Pet Medical Cannabidiol Industry Drivers
  3. 2.3 Pet Medical Cannabidiol Industry Opportunities and Challenges
  4. 2.4 Pet Medical Cannabidiol Industry Restraints
3 Pet Medical Cannabidiol Market by Company
  1. 3.1 Global Pet Medical Cannabidiol Company Revenue Ranking in 2025
  2. 3.2 Global Pet Medical Cannabidiol Revenue by Company (2021-2026)
  3. 3.3 Global Pet Medical Cannabidiol Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Medical Cannabidiol Average Price by Company (2021-2026)
  5. 3.5 Global Pet Medical Cannabidiol Company Ranking (2024-2026)
  6. 3.6 Global Pet Medical Cannabidiol Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Medical Cannabidiol Company Product Type and Application
  8. 3.8 Global Pet Medical Cannabidiol Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Medical Cannabidiol Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Medical Cannabidiol Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Medical Cannabidiol Market by Type
  1. 4.1 Pet Medical Cannabidiol Type Introduction
  2. 4.1.1 Oral Cannabidiol
  3. 4.1.2 Topical Cannabidiol
  4. 4.2 Global Pet Medical Cannabidiol Sales Volume by Type
  5. 4.2.1 Global Pet Medical Cannabidiol Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pet Medical Cannabidiol Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pet Medical Cannabidiol Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pet Medical Cannabidiol Sales Value by Type
  9. 4.3.1 Global Pet Medical Cannabidiol Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pet Medical Cannabidiol Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pet Medical Cannabidiol Sales Value Share by Type (2021-2032)
5 Pet Medical Cannabidiol Market by Application
  1. 5.1 Pet Medical Cannabidiol Application Introduction
  2. 5.1.1 Anaesthetization
  3. 5.1.2 Stimulate Appetite
  4. 5.1.3 Relieve Anxiety
  5. 5.1.4 Others
  6. 5.2 Global Pet Medical Cannabidiol Sales Volume by Application
  7. 5.2.1 Global Pet Medical Cannabidiol Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pet Medical Cannabidiol Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pet Medical Cannabidiol Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pet Medical Cannabidiol Sales Value by Application
  11. 5.3.1 Global Pet Medical Cannabidiol Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pet Medical Cannabidiol Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pet Medical Cannabidiol Sales Value Share by Application (2021-2032)
6 Pet Medical Cannabidiol Regional Sales and Value Analysis
  1. 6.1 Global Pet Medical Cannabidiol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Medical Cannabidiol Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Medical Cannabidiol Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Medical Cannabidiol Sales by Region (2027-2032)
  5. 6.3 Global Pet Medical Cannabidiol Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Medical Cannabidiol Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Medical Cannabidiol Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Medical Cannabidiol Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Medical Cannabidiol Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Medical Cannabidiol Sales Value (2021-2032)
  12. 6.6.2 North America Pet Medical Cannabidiol Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Medical Cannabidiol Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Medical Cannabidiol Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Medical Cannabidiol Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Medical Cannabidiol Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Medical Cannabidiol Sales Value (2021-2032)
  21. 6.9.2 South America Pet Medical Cannabidiol Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Medical Cannabidiol Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Medical Cannabidiol Sales Value Share by Country, 2025 VS 2032
7 Pet Medical Cannabidiol Country-level Sales and Value Analysis
  1. 7.1 Global Pet Medical Cannabidiol Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Medical Cannabidiol Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Medical Cannabidiol Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Medical Cannabidiol Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Medical Cannabidiol Sales by Country (2027-2032)
  6. 7.4 Global Pet Medical Cannabidiol Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Medical Cannabidiol Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Medical Cannabidiol Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Medical Cannabidiol Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Medical Cannabidiol Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Medical Cannabidiol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Canna-Pet
  2. 8.1.1 Canna-Pet Company Information
  3. 8.1.2 Canna-Pet Business Overview
  4. 8.1.3 Canna-Pet Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Canna-Pet Pet Medical Cannabidiol Product Portfolio
  6. 8.1.5 Canna-Pet Recent Developments
  7. 8.2 Holistic Hound
  8. 8.2.1 Holistic Hound Company Information
  9. 8.2.2 Holistic Hound Business Overview
  10. 8.2.3 Holistic Hound Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Holistic Hound Pet Medical Cannabidiol Product Portfolio
  12. 8.2.5 Holistic Hound Recent Developments
  13. 8.3 BATCH
  14. 8.3.1 BATCH Company Information
  15. 8.3.2 BATCH Business Overview
  16. 8.3.3 BATCH Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BATCH Pet Medical Cannabidiol Product Portfolio
  18. 8.3.5 BATCH Recent Developments
  19. 8.4 Choom Holdings
  20. 8.4.1 Choom Holdings Company Information
  21. 8.4.2 Choom Holdings Business Overview
  22. 8.4.3 Choom Holdings Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Choom Holdings Pet Medical Cannabidiol Product Portfolio
  24. 8.4.5 Choom Holdings Recent Developments
  25. 8.5 Receptra Naturals
  26. 8.5.1 Receptra Naturals Company Information
  27. 8.5.2 Receptra Naturals Business Overview
  28. 8.5.3 Receptra Naturals Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Receptra Naturals Pet Medical Cannabidiol Product Portfolio
  30. 8.5.5 Receptra Naturals Recent Developments
  31. 8.6 Curaleaf
  32. 8.6.1 Curaleaf Company Information
  33. 8.6.2 Curaleaf Business Overview
  34. 8.6.3 Curaleaf Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Curaleaf Pet Medical Cannabidiol Product Portfolio
  36. 8.6.5 Curaleaf Recent Developments
  37. 8.7 Trulieve Cannabis
  38. 8.7.1 Trulieve Cannabis Company Information
  39. 8.7.2 Trulieve Cannabis Business Overview
  40. 8.7.3 Trulieve Cannabis Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Trulieve Cannabis Pet Medical Cannabidiol Product Portfolio
  42. 8.7.5 Trulieve Cannabis Recent Developments
  43. 8.8 Pure Spectrum
  44. 8.8.1 Pure Spectrum Company Information
  45. 8.8.2 Pure Spectrum Business Overview
  46. 8.8.3 Pure Spectrum Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pure Spectrum Pet Medical Cannabidiol Product Portfolio
  48. 8.8.5 Pure Spectrum Recent Developments
  49. 8.9 Cannabis Strategies Acquisition
  50. 8.9.1 Cannabis Strategies Acquisition Company Information
  51. 8.9.2 Cannabis Strategies Acquisition Business Overview
  52. 8.9.3 Cannabis Strategies Acquisition Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cannabis Strategies Acquisition Pet Medical Cannabidiol Product Portfolio
  54. 8.9.5 Cannabis Strategies Acquisition Recent Developments
  55. 8.10 Pet Releaf
  56. 8.10.1 Pet Releaf Company Information
  57. 8.10.2 Pet Releaf Business Overview
  58. 8.10.3 Pet Releaf Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pet Releaf Pet Medical Cannabidiol Product Portfolio
  60. 8.10.5 Pet Releaf Recent Developments
  61. 8.11 Diamond CBD
  62. 8.11.1 Diamond CBD Company Information
  63. 8.11.2 Diamond CBD Business Overview
  64. 8.11.3 Diamond CBD Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Diamond CBD Pet Medical Cannabidiol Product Portfolio
  66. 8.11.5 Diamond CBD Recent Developments
  67. 8.12 PotNetwork Holdings
  68. 8.12.1 PotNetwork Holdings Company Information
  69. 8.12.2 PotNetwork Holdings Business Overview
  70. 8.12.3 PotNetwork Holdings Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 PotNetwork Holdings Pet Medical Cannabidiol Product Portfolio
  72. 8.12.5 PotNetwork Holdings Recent Developments
  73. 8.13 Kat's Naturals
  74. 8.13.1 Kat's Naturals Company Information
  75. 8.13.2 Kat's Naturals Business Overview
  76. 8.13.3 Kat's Naturals Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Kat's Naturals Pet Medical Cannabidiol Product Portfolio
  78. 8.13.5 Kat's Naturals Recent Developments
  79. 8.14 Bluebird Botanicals
  80. 8.14.1 Bluebird Botanicals Company Information
  81. 8.14.2 Bluebird Botanicals Business Overview
  82. 8.14.3 Bluebird Botanicals Pet Medical Cannabidiol Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bluebird Botanicals Pet Medical Cannabidiol Product Portfolio
  84. 8.14.5 Bluebird Botanicals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Medical Cannabidiol Value Chain Analysis
  2. 9.1.1 Pet Medical Cannabidiol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Medical Cannabidiol Sales Mode & Process
  6. 9.2 Pet Medical Cannabidiol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Medical Cannabidiol Distributors
  9. 9.2.3 Pet Medical Cannabidiol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst